Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

New schizophrenia cases linked to cannabis use disorder more than doubled in Ontario after legalisation of drug ...

A new Canadian study shows a tripling of schizophrenia cases linked to cannabis use disorder since the country legalized it.

Research from Aristotle University of Thessaloniki, Greece reveals that over 26% of stable patients with schizophrenia ...

Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...

Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has submitted a Letter of Intent to the U.S. Food ...

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...